Tenderwize
Zurück zur Suche

Open House Discount Agreement for Urapidil

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 186 days left·Open·Supplies
Structured notice only
Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Urapidil, ATC C02CA06

60/100

Opportunity Score

Needs reviewLow complexity
SuppliesOpen
Warum diese Bewertung?

Chance

60 / 100

Komplexität

20 / 100

Risikofaktoren

EU funding flag inconsistency: structured data says EU funded, XML notice says no EU funds. May affect eligibility or r...

Possibility that open house contracts are replaced by exclusive contracts during term, terminating open house agreement...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Überblick

Moderate opportunity

Wichtige Fakten

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Pharmaceutical products with active ingredient Urapidil (ATC C02CA06)
  • Non-exclusive discount agreements under §130a Abs. 8/130c Abs. 1 SGB V
Vollständige Zusammenfassung anzeigen

Open house non-exclusive discount agreement for the active ingredient Urapidil (ATC C02CA06) under German social code SGB V. Contract period 01.05.2025–30.04.2027 with rolling enrollment. No competitive selection; all eligible pharmaceutical companies can join. No estimated value provided. EU funding flag inconsistent (structured data: true, XML notice: false). Electronic submission not allowed.

Risiken

EU funding flag inconsistency: structured data says EU funded, XML notice says no EU funds. May affect eligibility or r...

Possibility that open house contracts are replaced by exclusive contracts during term, terminating open house agreement...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

  • Pharmaceutical company must be a 'pharmazeutischer Unternehmer' authorized to market Urapidil products in Germany
  • Drugs must be authorized and marketable in Germany (listed in Lauer-Taxe or verified via AMIce database)

Administrative

  • Submission of signed contract documents, proof of marketability, and authorization evidence

Anforderungen können unvollständig sein.

Auftraggeber

Lose (1)

LOT-0001

Open House Discount Agreement for Urapidil

Non-exclusive discount contract for Urapidil pharmaceuticals. Uniform terms, no negotiations. Contracts run up to 24 months, ending no later than 30.04.2027. First enrollment deadline 31.03.2025 for start 01.05.2025. Subsequent enrollments possible each month.

SuppliesEU fundedElectronic submission

Ort

Eisenberg, Germany

Dauer

Apr 2025 - Apr 2027

Kategorie

Pharmaceutical products

Frist

Deadline Feb 28, 2027

Vergabedetails

Veröffentlichungsdatum
12 Mar 2025
Sprachen
German

Referenzmetadaten

Rechtsgrundlage
32014L0024

Referenz-IDs

Ausschreibungs-ID
162677-2025

Dokumente (1)

Ähnliche Ausschreibungen